| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pmid27998201-compound-9 | cathepsin b | NA | Preclinical target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | patented | unknown |
| pmid27998201-compound-9 | cathepsin k | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | patented | unknown |
| pmid27998201-compound-9 | cathepsin l | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | patented | unknown |
| pmid27998201-compound-9 | cathepsin s | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Rheumatoid Arthritis[MeSHID:D001172] |
NA | patented | unknown |
| click here to return to the previous page | ||||||||